According to recent reports from the media, former Capital Markets Authority (CMA) director Paul Muthaura and former CEO of the Kenya Association of Manufacturers (KAM) Phyllis Wakiaga have joined the board of directors of British American Tobacco (BAT) Kenya subsidiary. At the same time, company secretary Kathryne Maundu has resigned, and Waeni Ngea has been appointed as her successor.
Filis Vicky Aga is currently serving as a senior advisor at the Tony Blair Institute for Global Change and also holds positions as a non-executive director at the Kenya National Highways Authority, the Institute of Economic Affairs, the International Center for Women's Research (Africa Board), and the Board of Trustees at the American University.
Vaiani Ng'ang'a joined BAT Kenya in July as the Head of the Legal and Compliance Department for East and South Africa. Prior to that, he held the position of Head of Legal and Compliance and Company Secretary at Bamburi Cement Manufacturing Company for a period of three years.
Former BAT secretary Catherine Mandu is now the CEO of the African Carbon Market Initiative. She has previously served as the CEO and overall head of ICEA LION Insurance Company's headquarters, the CEO of the Capital Markets Authority in Kenya, and an independent consultant at EMRD Advisory Limited.
The Chairman of BAT Kenya Board expressed congratulations and welcomed the newly appointed senior officials to join the board.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
